当前位置: 首页 > 期刊 > 《中国医学创新》 > 202025
编号:13809811
丹参酮ⅡA联合尼可地尔对冠心病左主干病变患者的临床疗效分析(4)
http://www.100md.com 2020年9月5日 《中国医学创新》 202025
     [6] Wei B,You M,Ling J,et al.Regulation of antioxidant system, lipids and fatty acid β-oxidation contributes to the cardioprotective effect of sodium tanshinone ⅡA sulphonate in isoproterenol-induced myocardial infarction in rats[J].Atherosclerosis,2013,230(1):148-156.

    [7] Zhao X T,Zhang C F,Liu Q J.Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention[J].BMC Cardiovascular Disorders ......
上一页1 2 3 4

您现在查看是摘要页,全文长 2863 字符